Interlocking Directorates – Not Just a Section 8 Issue
October 6, 2017, Law360
By: Nathan T. Newman
Publications
Sharing our insights
search
Mandating Pro-Manmarriage or Equal Access in the Marketplace
October 2017, Equality Blog
By: Chad M. Eggspuehler
How Bristol-Myers Squibb May Transform Class Actions
October 2017, Law360
By: Richard A. Dean, Michael J. Ruttinger
Satellite Witnesses Part II: Strategic Considerations Before and During Trial
October 2017, Second Edition
By: Sherry A. Knutson
The Resale Price Maintenance Two-Step
October 2017, DRI's For The Defense
By: Stephanie A. Rzepka
Strategies and Considerations When Breaking Up Mass Actions After BMS
September 6, 2017, DRI's The Voice
By: Madeline B. Dennis, Seth H. Wamelink
The Proper Care and Feeding of Your Trademarks
Summer 2017, In-House Defense Quarterly
By: Sandra J. Wunderlich
Over the Counter Products: Is Implied Preemption a Viable Defense?
September 2017, DRI's For The Defense
By: Richard A. Dean
Trejo v. Johnson & Johnson: The Death of Design Defect in California?
August 2017, DRI's The Voice
By: Nicholas V. Janizeh, Amanda Villalobos
Design Defect Implied Preemption Is Not Just for Drugs
August 2017, Drug & Device Law Blog
By: Richard A. Dean